Biotechnology Stocks I Performance Guide: Halozyme Therapeutics, Inc. (HALO)
HALO has no dividends.
Table and Chart of HALO Performance
See what a $1,000 investment in HALO is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| HALO Returns | |
|---|---|
| Start Date | Sep-30-2014 |
| Start Price | $9.10 |
| End Date | Sep-19-2024 |
| End Price | $59.50 |
| # Prices | 121 |
| Min Date | Feb-29-2016 |
| Min Price | $8.13 |
| Max Date | Aug-30-2024 |
| Max Price | $63.85 |
| Total Return | 553.85% |
| Annualized Return | 20.47% |
| Current Value of $1,000 Purchase | $6,538 |
| Number Returns | 7,260 |
| Average Return | 107.36% |
| Number Profitable Returns | 5,983 |
| Percent Profitable Returns | 82.41% |
| Number Unprofitable Returns | 1,277 |
| Percent Unprofitable Returns | 17.59% |
| Profitable to Unprofitable Returns Ratio | 4.69 |
| HALO Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 17.060 | Price to Sales | 15.06 |
| Earnings per Share | $0.0000 |
| PE Ratio | 480799000 |
| PE to Growth Ratio | 24.15 |
| Price to Book | 9.04 |
| PRICE DATA | |
| 52 Week High | $1.278 |
| 52 Week Low | $65.53 |
| Analyst Target Price | $0.047 |
| 50-Day Moving Average | $32.83 |
| 200-Day Moving Average | $57.92 |
| FINANCIAL DATA | |
| Revenue per Share | $2.58 |
| Revenue | $2 |
| Profit Margin | 678% |
| Return on Equity | 13.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
HALO Compare Returns with S&P 500
HALO Trendline Chart
HALO Moving Average Chart
HALO Stock Return Map - See Patterns of Gains and Losses
HALO Stock Returns/Purchase Dates